Drug recall · June 21, 2017
Levophed norepinephrine bitartrate recall
Why: GMP Deviation; A foreign stopper was observed during packaging of a lot of product.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Levophed norepinephrine bitartrate, injection, USP, 4 mg /4 mL (1 mg/mL),Rx only, Hospira, Inc. Lake Forest, IL --- NDC 0409-3375-04
- Lots / codes
720503A, 720603A (Canada only)
- Quantity
- (720503A): 43,200 vials, (720603A): 400 vials
- Company
- Hospira Inc., A Pfizer Company, Lake Forest, IL
- Distribution
- Nationwide, Canada and Singapore
- Initiated
- May 18, 2017 · Voluntary: Firm initiated
- Classified
- June 9, 2017
- Reported
- June 21, 2017
- Ended
- May 2, 2019
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Norepinephrine
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.